Inflammaging. Aging inflammatory origin;Inflammaging. Envejecimiento de origen inflamatorio

Revista de Investigacion Clinica

Volumn 61, Issue 4, 2009, Pages 327-336

  Navarrete Reyes, Ana Patricia ^a   Montaña Álvarez, Mariano ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Aging; Aging theories; Inflammation; Innate immunity; Nuclear factor kappa B

Indexed keywords

FORKHEAD BOX O; FORKHEAD TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NUCLEIC ACID; SIRTUIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CHRONIC INFLAMMATION; DIABETES MELLITUS; DISEASE COURSE; FUNCTIONAL STATUS; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE SYSTEM; LIFE EXPECTANCY; OXIDATIVE STRESS; REVIEW;

AGING; HUMANS; INFLAMMATION;

EID: 70350160191     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005; 579: 2035-2039 (Pubitemid 40469666)
2. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007; 128: 92-105.
3. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-254
4. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 2008; 7: 83-105.
5. Ginaldi L, Mengoli LP, De Martines M. Rev Clin Gerontol 2007; 17: 161-169
6. Giunta S. Is inflammaging an auto[innate]immunity subclinical syndrome? Immun Ageing 2006; 3: 12.
7. Delves PJ, Roitt IM. The immune system (First of two parts). N Engl J Med 2000; 343: 37-49. (Pubitemid 30447991)
8. Delves PJ, Roitt IM. The immune system (Second of two parts). N Engl J Med 2000; 343: 108-117
9. Chakravarti B, Abraham GN. Aging and T-cell mediated immunity. Mech Ageing Dev 1999; 108: 183-206.
10. Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev 2004; 3: 401-406
11. Pawelec G. Immunosenescence comes of age. EMBO reports 2007; 8: 220-223
12. Zingarelli B. Nuclear factor-kB. Crit Care Med 2005; 33: S414-S416.
13. Hayden MS, Ghosh S. Shared principles in NF-kB signaling. Cell 2008;132:344-362
14. Aggarwal BB. Nuclear factor-kB: The enemy within. Cancer Cell 2004; 6: 203-208
15. Abraham E. NF-kappaB activation. Critical Care Med 2000; 28: N100-N104.
16. Salvioli S, Capri M, Valensin S, Ieri P, Monti D, Ottaviani E, et al. Inflamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology. Curr Pharm Des 2006; 12: 3161-3171 (Pubitemid 44227576)
17. Salminen A, Suuronen T, Huuskonen J, Kaarniranta K. NEMO shuttle: a link between DNA damage and NF-kappaB activation in progeroid syndromes? Biochem Biophys Res Commun 2008; 367: 715-718
18. Burgering BM. A brief introduction to FOXOlogy. Oncogene 2008; 27: 2258-2262
19. Peng SL. FoxO in the immune system. Oncogene 2008; 27: 2337-2344
20. Partidge L, Brüning JC. Forkhead transcription factors and ageing. Oncogene 2008; 27: 2351-2363
21. North BJ, Verdin E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biology 2004; 5: 1-12. (Pubitemid 38735659)
22. Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J. Sirtuins: The "magnificent seven", function, metabolism and longevity. Ann Med 2007; 39: 335-345
23. Salminen A, Ojala J, Huuskonen J, Kauppinen A, Suuronen T, Kaarniranta K. Interaction of aging-associated signaling cascades: Inhibition of NF-kappaB signaling and longevity factors FoxOs and SIRT1. Cell Mol Life Sci 2008; 65: 1049-1058
24. Lanske B, Razzaque MS. Premature aging in klotho mutant mice: cause or consequence? Ageing Res Rev 2007; 6: 73-79
25. Yakamoto M, Clark JD, Pastor JV, et al. Regulation of oxidative stress by the anti-aging hormona klotho. J Biol Chem 2005; 280: 38029-38034 (Pubitemid 41642417)
26. Roubenoff R, Parise H, Payette H, Abad LW, D'Agostino R, Jacques PF, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med 2003; 115: 429-435 (Pubitemid 37237554)
27. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg JB, Pedersen BK, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 2003; 115: 278-283 (Pubitemid 37088189)
28. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006; 80: 219-227
29. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson BO, Ferguson FG. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000; 121: 187-201.
30. Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson BO, Ferguson F. Expansion of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 2002; 37: 445-453
31. De Martinis M, Di Benedetto MC, Mengoli LP, Ginaldi L. Senile osteoporosis: is it an immune-mediated disease? Inflamm Res 2006; 55: 399-404.
32. Ginaldi L, Di Benedetto MC, De Martines M. Osteoporosis, inflammation and ageing. Immunity & Aging 2005; 2: 14.
33. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in Older Adults: Evidence for a Phenotype. J Gerontol Med Sci 2001; 56A: M146-M156.
34. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities. Arch Intern Med 2002; 162: 2333-2341
35. Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, et al. Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women with High Interleukin-6 Serum Levels. J Am Geriatr Soc 2002; 50: 1947-1954 (Pubitemid 35462439)
36. Leng SX, Xue QL, Tian J, Walston JD, Fried LP. Inflammation and frailty in older women. J Am Geriatr Soc 2007; 55: 864-871
37. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999; 47: 755-756 (Pubitemid 29266628)
38. Schmaltz HN, Fried LP, Xue QL, Walston J, Leng SX, Semba RD. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc 2005; 53: 747-754 (Pubitemid 41656918)
39. Morley JE. Frailty. Med Clin N Am 2006; 90: 837-847
40. Bautmans I, Njemini R, Predom H, Lemper JC, Mets T. Muscle endurance in elderly nursing home residents is related to fatigue perception, mobility and circulating tumor necrosis factor-alpha, interleukin-6, and heat shock protein 70. J Am Geriatr Soc 2008; 56: 389-396 (Pubitemid 351327923)
41. Florez H, Troen BR. Fat and inflammaging: a dual path to unfitness in elderly people? J Am Geriatr Soc 2008; 56: 558-560
42. Payette H, Roubenoff R, Jacques PF, Dinarello CA, Wilson PW, Abad LW, et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: The Framingham Heart Study. J Am Geriatr Soc 2003; 51: 1237-1243 (Pubitemid 37093572)
43. Akama KT, Albanese C, Pestell RG, Van Eldik LJ. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NF kappa B dependent mechanism. Proc Natl Acad Sci USA 1998; 95: 5795-5800 (Pubitemid 28224176)
44. Brüünsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin N Am 2003; 23: 15-39. (Pubitemid 36268302)
45. Griffin WST. Inflammation and neurodegenerative diseases. Am J Clin Nutr 2006; 83: 470S-474S.
46. Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arteriscker Thromb Vasc Biol 1998; 18: 1199-1202 (Pubitemid 28376175)
47. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334 (Pubitemid 32656163)
48. Figaro MK, Kritchevsky SB, Resnick HE, Shorr RI, Butler J, Shintani A, et al. Diabetes, inflammation, and functional decline in older adults: Findings from the Health, Aging and Body Composition (ABC) Study. Diabetes Care 2006; 29: 2039-2045 (Pubitemid 44871184)
49. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 2003; 108: 2317-2322 (Pubitemid 37413536)
50. Franceschi C, Bonafè M. Centenarians as a model for healthy aging. Biochem Soc Trans 2003; 31: 457-461
51. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented? Nutrition Reviews 2007; 65: S173-S176.
52. LaRosa JC. Pleiotropic effects of statins and their clinical significance. Am J Cardiol 2001; 88: 291-293 (Pubitemid 32721958)
53. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999; 100: 230-235 (Pubitemid 29340127)
54. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med 2000; 6: 1399-1402 (Pubitemid 32001026)